FDA Expert Panel
The palest skin may be prohibited from using a tanning bed.
That is just one of the newest restrictions under consideration by an FDA advisory panel, reports WebMD.
The panel met March 25 and among other considerations – restricting use to adults age 18 and older.
Tanning beds are classified as a Class I medical device. The panel is recommending changing that designation from the least restrictive Class I to a Class II designation.
That would impose changes on tanning bed manufacturers such as labeling requirements and performance standards.
Others on the panel want tanning beds made a Class III device which requires manufacturers submit to pre-market approval.
Light-skinned persons would be defined as those with very pale skin, such as red heads with freckles, who burn instead of tan, and are classified as Fitzpatrick skin type 1.
The Melanoma Research Foundation says the ultraviolet radiation from tanning lamps before the age of 30 increases the risk of melanoma by 75 percent.
The American Cancer Society notes that there were nearly 69,000 new cases of melanoma last year resulting in with 8,600 deaths.
About 30 million Americans go to a tanning salon at least once a year.
Other recommendations are:
- Strengthening protective eyewear
- Requiring users to read all warnings and accept them before the machine can be turned on
- Establishing a registry program for users
- Collecting data on the radiation put out by tanning beds and collecting that data possibly for a registry
- Upgrading tanning bed operator education
- Restricting tanning bed use by pregnant women and people who take certain drugs
The Indoor Tanning Association represents 18,000 tanning salons and says the current FDA regulations are adequate.
The expert panel’s recommendations are another restriction on the industry, which now much pay a 10 percent tax as part of health care reform.
The Hill reports that the country will never see the $2.7 billion from the tax as estimated by the Joint Commission on Taxation, primarily because there are too few tanning salons.
The FDA does not have to adopt expert panel recommendations, but often does. #